SCHEMBL801128

SCHEMBL801128

O=P(c1ccccc1)(c1ccccc1)c1cc(-n2c3ccc4ccccc4c3c3c4ccccc4ccc32)cc(P(=O)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.39
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ PTK2B Q14289 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ATM Q13315 1/20 0.33
▸ AHR P35869 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAPK3 P27361 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ HSD17B10 Q99714 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801127 0.93 NPSR1 (0.40) NPSR1JAK2JAK3L3MBTL1PTK2B
SCHEMBL30780039 0.82 KDM4E (0.52) NPSR1L3MBTL1KDM4EATMMEN1
SCHEMBL801204 0.82 KDM4E (0.52) NPSR1L3MBTL1KDM4EATMMEN1
SCHEMBL801129 0.81 NPSR1 (0.39) NPSR1JAK2JAK3L3MBTL1KDM4E
SCHEMBL801506 0.81 KDM4E (0.41) NPSR1L3MBTL1KDM4EATMMEN1
SCHEMBL801540 0.79 KDM4E (0.42) NPSR1JAK2JAK3L3MBTL1KDM4E
SCHEMBL18668052 0.79 NPSR1 (0.36) NPSR1CYP1A2ALDH1A1HSD17B10LMNA
SCHEMBL29551411 0.79 KDM4E (0.52) NPSR1L3MBTL1KDM4EATMMEN1
SCHEMBL14923168 0.79 KDM4E (0.52) NPSR1L3MBTL1KDM4EATMMEN1
SCHEMBL801143 0.78 KDM4E (0.41) NPSR1L3MBTL1PTK2BKDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 NPSR1 4411/4885JAK2 1051/4885JAK3 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback